143 related articles for article (PubMed ID: 31691056)
21. Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.
Soria G; Ofri-Shahak M; Haas I; Yaal-Hahoshen N; Leider-Trejo L; Leibovich-Rivkin T; Weitzenfeld P; Meshel T; Shabtai E; Gutman M; Ben-Baruch A
BMC Cancer; 2011 Apr; 11():130. PubMed ID: 21486440
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2-) subtype breast cancer by quantum-dot-based molecular imaging.
Zhu YY; Chen C; Li JJ; Sun SR
Int J Nanomedicine; 2018; 13():3795-3803. PubMed ID: 29988769
[TBL] [Abstract][Full Text] [Related]
23. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
[TBL] [Abstract][Full Text] [Related]
24. The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.
Yaal-Hahoshen N; Shina S; Leider-Trejo L; Barnea I; Shabtai EL; Azenshtein E; Greenberg I; Keydar I; Ben-Baruch A
Clin Cancer Res; 2006 Aug; 12(15):4474-80. PubMed ID: 16899591
[TBL] [Abstract][Full Text] [Related]
25. Role of RANTES and its receptor in gastric cancer metastasis.
Cao Z; Xu X; Luo X; Li L; Huang B; Li X; Tao D; Hu J; Gong J
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):342-347. PubMed ID: 21671175
[TBL] [Abstract][Full Text] [Related]
26. Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.
Aldinucci D; Lorenzon D; Cattaruzza L; Pinto A; Gloghini A; Carbone A; Colombatti A
Int J Cancer; 2008 Feb; 122(4):769-76. PubMed ID: 17935139
[TBL] [Abstract][Full Text] [Related]
27. The β-catenin signaling pathway induces aggressive potential in breast cancer by up-regulating the chemokine CCL5.
Yasuhara R; Irié T; Suzuki K; Sawada T; Miwa N; Sasaki A; Tsunoda Y; Nakamura S; Mishima K
Exp Cell Res; 2015 Oct; 338(1):22-31. PubMed ID: 26363360
[TBL] [Abstract][Full Text] [Related]
28. Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.
Sugasawa H; Ichikura T; Kinoshita M; Ono S; Majima T; Tsujimoto H; Chochi K; Hiroi S; Takayama E; Saitoh D; Seki S; Mochizuki H
Int J Cancer; 2008 Jun; 122(11):2535-41. PubMed ID: 18246596
[TBL] [Abstract][Full Text] [Related]
29. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
30. CCL5 rs2107538 Polymorphism Increased the Risk of Tuberculosis in a Sample of Iranian Population.
Kouhpayeh HR; Taheri M; Baziboroon M; Naderi M; Bahari G; Hashemi M
Prague Med Rep; 2016; 117(2-3):90-97. PubMed ID: 27668525
[TBL] [Abstract][Full Text] [Related]
31. Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma.
Sima AR; Sima HR; Rafatpanah H; Hosseinnezhad H; Ghaffarzadehgan K; Valizadeh N; Mehrabi Bahar M; Hakimi HR; Masoom A; Noorbakhsh A; Razavi Satvati N; Raziee HR
J Gastrointest Cancer; 2014 Dec; 45(4):476-80. PubMed ID: 25301002
[TBL] [Abstract][Full Text] [Related]
32. Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Ning Y; Cremolini C; Antoniotti C; Borelli B; Mashima T; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Lonardi S; Yamaguchi T; Falcone A; Loupakis F; Lenz HJ
Clin Colorectal Cancer; 2018 Jun; 17(2):e395-e414. PubMed ID: 29606345
[TBL] [Abstract][Full Text] [Related]
33. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
Murooka TT; Rahbar R; Fish EN
Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
[TBL] [Abstract][Full Text] [Related]
34. Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer.
Zazo S; González-Alonso P; Martín-Aparicio E; Chamizo C; Luque M; Sanz-Álvarez M; Mínguez P; Gómez-López G; Cristóbal I; Caramés C; García-Foncillas J; Eroles P; Lluch A; Arpí O; Rovira A; Albanell J; Madoz-Gúrpide J; Rojo F
Mol Cancer Ther; 2020 Aug; 19(8):1696-1707. PubMed ID: 32404410
[TBL] [Abstract][Full Text] [Related]
35. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Vaday GG; Peehl DM; Kadam PA; Lawrence DM
Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
[TBL] [Abstract][Full Text] [Related]
36. Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.
Juan CC; Chen KH; Chen CW; Ho CH; Wang PH; Chen HS; Hwang JL; Lin YH; Seow KM
Fertil Steril; 2021 Oct; 116(4):1139-1146. PubMed ID: 34119324
[TBL] [Abstract][Full Text] [Related]
37. Role for ezrin in breast cancer cell chemotaxis to CCL5.
Li J; Tu Y; Wen J; Yao F; Wei W; Sun S
Oncol Rep; 2010 Oct; 24(4):965-71. PubMed ID: 20811677
[TBL] [Abstract][Full Text] [Related]
38. CCL5 secreted by luminal B breast cancer cells induces polarization of M2 macrophages through activation of MEK/STAT3 signaling pathway via CCR5.
Zhu YY; Zhao YC; Chen C; Xie M
Gene; 2022 Feb; 812():146100. PubMed ID: 34864094
[TBL] [Abstract][Full Text] [Related]
39. E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1.
Pham K; Huynh D; Le L; Delitto D; Yang L; Huang J; Kang Y; Steinberg MB; Li J; Zhang L; Liu D; Tang MS; Liu C; Wang H
Cancer Lett; 2020 Oct; 491():132-145. PubMed ID: 32829009
[TBL] [Abstract][Full Text] [Related]
40. Autocrine CCL5 promotes tumor progression in esophageal squamous cell carcinoma in vitro.
Wu YC; Shen YC; Chang JW; Hsieh JJ; Chu Y; Wang CH
Cytokine; 2018 Oct; 110():94-103. PubMed ID: 29705397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]